Mantle Cell Lymphoma
Mantle cell lymphoma (MCL) is just one of 50-60 known
Mantle cell lymphoma (MCL) is a rare type of B-Cell lymphoma. It
The Lymphoma Research Foundation (www
Specialty biopharmaceutical company Biovest
The FDA has made two significant changes to the dosage and safety information for the
Because science has only recently became familiar with mantle cell lymphoma, there aer not
Scientists have undertaken the first truly comprehensive analysis of
Results of a recently published Phase II study by Italian researchers indicate that
The U.S. Food and Drug Administration today has approved Imbruvica (ibrutinib) for the
Last week at the 54th American Society of Hematology Annual Meeting and Exposition in Atlanta,
The Leukemia and Lymphoma Society, the largest charity in the world dedicated to blood
Biovest International, makers of the personalized therapeutic lymphoma vaccine BiovaxID, have
Changing R-CHOP improved outcomes in patients with mantle cell lymphoma (MCL), according
At the recent ASH meeting in San Diego, researchers from Italy presented data supporting the use